openPR Logo
Press release

Cytomegalovirus Assay Market Registering a Strong Growth by 2017 to 2027

10-26-2018 02:49 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Cytomegalovirus Assay Market Registering a Strong Growth

CMV diagnostics turn out to be exceptionally basic for immunocompromised people and pregnant ladies as well. Cytomegaloviruses are one of the main sources of mental hindrance in kids and viral diseases. A cytomegalovirus can cause asymptomatic contaminations in immunocompromised people and can be transmitted to the embryo while pregnancy from his mom, which may show essential or intermittent disease. Hence, it require a proper analysis of essential contamination in the pregnant lady that can be founded on IgG and IgM eagerness assays, a standout amongst the most sensitive serological assays or other ordinary sub-atomic and virological techniques for infection discovery in blood.

Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=571

Cytomegalovirus has a place with the herpes viridae family and is a twice as stranded as DNA virus. This infection chiefly causes asymptomatic diseases or some of the time causes mild influenza like indications; and later stays dormant all through life, which may relapse. Hence, this infection can stay as a long lasting partner for a few people and can be a quiet killer for the others. Cytomegalovirus (CMV) contamination is described by the improvement of such antibodies, which is caused because of the disease of the infection that stays in a person's body for the duration of his life.

Cytomegalovirus is a common virus which belong to same family as herpesvirus. Cytomegalovirus causes cold sores and chickenpox. Cytomegalovirus is spread through contact spread with someone who have cytomegalovirus. It can also passed through body fluids such as saliva, urine and blood. Cytomegalovirus can cause serious disease such as retinitis, colitis, pneumonia, hepatitis and encephalitis. People with weak immune system can cause severe symptoms which affect eyes, lungs liver. Newborn babies with cytomegalovirus can have brain, liver and growth problems. Hearing loss is caused with the babies having cytomegalovirus infection. Cytomegalovirus is be detected through culture (human fibroblast), PCR, antigen assays, serologies, and cytopathology. Many cytomegalovirus assay are used for the detection of CMV IgG antibodies such as enzyme-linked immunosorbent assay (ELISA), indirect hemagglutination, radioimmunoassay and anticomplement immunofluorescence. Among all enzyme-linked immunosorbent assays (ELISAs) is widely used and is based on crude viral preparations.

Congenital CMV infection is been recognized as a leading cause of congenital infection and brain disease in children in U.S. About 20,000 to 40,000 infants are born each year in the U.S. with congenital CMV infection. Development and standardizing molecular diagnostic methods which will result in the availability of reliable, rapid, and simple methods for routine clinical use in near future. In addition, there is also growing interest in examining the feasibility of a cytomegalovirus screening program in conjunction with universal newborn hearing screening in newborn. Rapid culture methods are more comparable sensitivity and specificity to the standard cell culture assays and the results are available within 24 to 36 hours of sample taken. Saliva PCR assays are currently being assessed as a useful screening method for CMV infection in newborns. CMV infection has led to the development of diagnostic procedures for the rapid identification of CMV disease and infants with congenital infection.

View Full Report @ https://www.factmr.com/report/571/cytomegalovirus-assay-market

Cytomegalovirus Assay Market: Drivers and Restraints

Cytomegalovirus Assay Market is fueled owing to rise in prevalence of cytomegalovirus infection, growing awareness among population regarding herpes disease and technological advancement in the diagnosis of the cytomegalovirus. Moreover rise in the initiative taken by the government and development of healthcare infrastructure are anticipated to boost the cytomegalovirus assay market globally. Lack of awareness in developing and under developed countries and price sensitivity are the factor which hinder the growth of the cytomegalovirus assay market.

Cytomegalovirus Assay Market : Overview

Increase in cytomegalovirus infection cases propel the growth of the assay market. Patients who have undergone transplantation, new born and premature infants have higher risk of cytomegalovirus infection. New and traditional technique will increase the market of the cytomegalovirus assay market globally. Among all the test type antigenemia assay contributed the largest share which depend on the use of monoclonal antibodies that detect the viral pp65 antigen. The immense pace of research and development activities due to the large presence of biotechnology companies and pharmaceutical are the key factors contributes to the increase in the global cytomegalovirus assay market. Favorable government policies aims at the development of industries such as pharmaceuticals and biotechnology boost the cytomegalovirus assay market globally.

Cytomegalovirus Assay Market: Regional Outlook

Geographically, Cytomegalovirus Assay Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is projected to hold largest shares in the global market primarily due to growing incidence of Cytomegalovirus and innovations in diagnostic techniques. Asia pacific Cytomegalovirus assay market is anticipated to witness prominent growth during the forecast period owing to increased healthcare expenditure and repeated outbreaks of infectious diseases in developing countries such as India and China.

Cytomegalovirus Assay Market: Key Players

Some of the key players in the Cytomegalovirus Assay Market are Merck KGaA, Qiagen, Abcam plc, BioVision Inc, DiaSorin Molecular LLC, Norgen Biotek Corp. among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=571

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact us

Fact.MR

353-1-6111-593

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus Assay Market Registering a Strong Growth by 2017 to 2027 here

News-ID: 1332065 • Views:

More Releases from Fact.MR

Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
04-19-2024 | Health & Medicine
Fact.MR
Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
The global medical gloves market (医療用手袋市場) is projected to reach a valuation of over US$ 27,141.5 million by 2034, growing from an estimated worth of US$ 11,299 million in 2024, with a forecasted compound annual growth rate (CAGR) of 9.2% until 2034. The increasing emphasis on hygiene and infection control, particularly in healthcare environments, is driving demand for medical gloves. This demand is further fueled by stringent regulations governing healthcare standards.
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9.5 billion by 2033.
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9. …
The global Aerial Inspection Services is expected to reach a value of US$ 1.9 billion and is projected to grow at a compound annual growth rate (CAGR) of 17.5% over the next decade, reaching US$ 9.5 billion by 2033.Drone inspection services dominate this market, accounting for approximately 90.0% of the total aerial inspection services sector. Moreover, this segment represents a significant portion, around 25.0%, of the broader drone services market,
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
04-19-2024 | Health & Medicine
Fact.MR
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034. Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 2032
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 203 …
The Bonded Magnet Market is currently valued at around US$ 5.1 billion, and it is expected to experience substantial growth in the coming years. Projections suggest that the market will reach a valuation of US$ 10.9 billion by 2032, growing at an impressive compound annual growth rate (CAGR) of 7.8% from 2022 to 2032. Bonded magnets play a significant role in the global magnet market, accounting for approximately 14% of its

All 5 Releases


More Releases for Cytomegalovirus

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many
Cytomegalovirus Assay Market Latest Report with Forecast 2017-2027
Global Cytomegalovirus Assay Market: Snapshot CMV diagnostics turn out to be exceptionally basic for immunocompromised people and pregnant ladies as well. Cytomegaloviruses are one of the main sources of mental hindrance in kids and viral diseases. A cytomegalovirus can cause asymptomatic contaminations in immunocompromised people and can be transmitted to the embryo while pregnancy from his mom, which may show essential or intermittent disease. Hence, it require a proper analysis of
Cytomegalovirus Diagnostics Market to Record Ascending Growth by 2020
Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to
Global Cytomegalovirus Retinitis Market Size, Share | MarketResearchReports.biz
Latest industry research report on: Global Cytomegalovirus Retinitis Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Cytomegalovirus (CMV) Retinitis is caused by cytomegalovirus infection, which is a herpes-type virus that affects the retina of the human eye among patients having a weak immune system that could be due to conditions such as AIDS, leukemia and/or pregnancy. Symptomatic conditions include floaters, flashes, and blind spots besides
Human Papillomavirus and Cytomegalovirus Therapeutics Market Analysis & Trends 2 …
A report by Transparency Market Research forecasts the global human papillomavirus (HPV) therapeutics market to rise at a CAGR of 7.7% during the period between 2014 and 2020 to become worth US$2.34 bn by 2020 from US$1.40 bn in 2012. According to the report, the global cytomegalovirus (CMV) market will rise at a 1.49 % CAGR from 2014 to 2020 to attain a value of US$922.8 mn by 2020 from
Human Papillomavirus and Cytomegalovirus Therapeutics Market Growth Analysis 202 …
Some of the prominent names in The Global Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market are Valeant Pharmaceuticals, Roche AG, Perrigo Company plc, Fougera Pharmaceuticals, Clinigen Group plc., and Fresenius Kabi USA. Of them, Valeant Pharmaceuticals accounts for a leading share in the HPV therapeutics market and Roche AG accounts for a dominant share in the CMV therapeutics market. A report by Transparency Market Research forecasts the global human papillomavirus